CN102526581B - 一种用于治疗高血压疾病的中药组合物 - Google Patents
一种用于治疗高血压疾病的中药组合物 Download PDFInfo
- Publication number
- CN102526581B CN102526581B CN201210046109.XA CN201210046109A CN102526581B CN 102526581 B CN102526581 B CN 102526581B CN 201210046109 A CN201210046109 A CN 201210046109A CN 102526581 B CN102526581 B CN 102526581B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- grams
- root
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 42
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 10
- 239000002674 ointment Substances 0.000 claims abstract description 7
- 239000003814 drug Substances 0.000 claims description 52
- 210000000582 semen Anatomy 0.000 claims description 15
- 241000283956 Manis Species 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 8
- 241000190633 Cordyceps Species 0.000 claims description 7
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 7
- 241000180649 Panax notoginseng Species 0.000 claims description 7
- 239000009636 Huang Qi Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 20
- 235000004879 dioscorea Nutrition 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 2
- 241000405414 Rehmannia Species 0.000 abstract 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241000572565 Alpinia oxyphylla Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 241001523681 Dendrobium Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 241000305491 Gastrodia elata Species 0.000 abstract 1
- 241000146384 Glaux Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 240000001307 Myosotis scorpioides Species 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 230000035622 drinking Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 235000013974 saffron Nutrition 0.000 abstract 1
- 239000004248 saffron Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 37
- 210000004369 blood Anatomy 0.000 description 35
- 210000003734 kidney Anatomy 0.000 description 17
- 201000010099 disease Diseases 0.000 description 16
- 230000007812 deficiency Effects 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 12
- 230000036772 blood pressure Effects 0.000 description 11
- 208000002173 dizziness Diseases 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 210000002216 heart Anatomy 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 206010033557 Palpitations Diseases 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 230000035922 thirst Effects 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 206010022437 insomnia Diseases 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000035900 sweating Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 208000009205 Tinnitus Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000001914 calming effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 231100000886 tinnitus Toxicity 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 235000005903 Dioscorea Nutrition 0.000 description 3
- 241000234273 Dioscorea Species 0.000 description 3
- 235000000504 Dioscorea villosa Nutrition 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 241000208966 Polygala Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 241000219780 Pueraria Species 0.000 description 3
- 241000545442 Radix Species 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 206010043458 Thirst Diseases 0.000 description 3
- 208000012886 Vertigo Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 229940126678 chinese medicines Drugs 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000001631 hypertensive effect Effects 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 231100000889 vertigo Toxicity 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000021959 Abnormal metabolism Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 230000008065 myocardial cell damage Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000004987 nonapoptotic effect Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种用于治疗高血压疾病的中药组合物,由以下重量份数的原料药制成:三七15-20份、茯苓15-20份、枸杞子15-20份、黄芪15-20份、泽泻10-15份、石斛10-15份、白术10-15份、生地10-15份、熟地10-15份、山药8-16份、柏子仁8-16份、酸枣仁8-16份、丹皮8-16份、女贞子13-18份、天麻15-18份、益智仁9-16份、远志6-10份、穿山甲8-15份、酒制何首乌15-20份、酒山茱萸肉15-20份、丹参10-15份、葛根10-15份、冬虫夏草3-8份、西红花5-12份。本发明的中药组合物为浓缩型膏剂,通过微量口服,可达到有效治疗高血压病症的功效。经临床验证,本发明的中药组合物疗效安全可靠,无毒副作用,饮用方便,易于吸收,疗效快,治愈率高。
Description
技术领域
本发明涉及中药技术领域,具体涉及一种用于治疗高血压疾病的中药组合物。
背景技术
目前高血压患者较多,成逐年上升趋势,临床病症主要表现为头晕、头痛、失眠多梦、记忆力明显减退等,高血压还可引发多种疾病,如心、脑、肝、肾病等,高血压又被称为人类健康的“无形杀手”。目前治疗高血压疾病主要采用西药治疗,西药治疗的缺点是副作用大,甚至会伤及患者的生理机能,并且治疗费用高,治愈率低。
发明内容
本发明的目的在于提供一种用于治疗高血压疾病的中药组合物。
为了实现以上目的,本发明所采用的技术方案是:一种用于治疗高血压疾病的中药组合物,由以下重量份数的原料药制成:
三七15-20份 茯苓15-20份 枸杞子15-20份 黄芪15-20份
泽泻10-15份 石斛10-15份 白术10-15份 生地10-15份
熟地10-15份 山药8-16份 柏子仁8-16份 酸枣仁8-16份
丹皮8-16份 女贞子13-18份 天麻15-18份 益智仁9-16份
远志6-10份 穿山甲8-15份 酒制何首乌15-20份
酒山茱萸肉15-20份 丹参10-15份 葛根10-15份 冬虫夏草3-8份
西红花5-12份。其中,葛根优选天然葛根。
所述用于治疗高血压疾病的中药组合物为口服浓缩膏剂。
本发明提供的用于治疗高血压疾病的中药组合物的制备方法,包括以下步骤:
(1)按以下重量份数称取原料:三七15-20份、茯苓15-20份、枸杞子15-20份、黄芪15-20份、泽泻10-15份、石斛10-15份、白术10-15份、生地10-15份、熟地10-15份、山药8-16份、柏子仁8-16份、酸枣仁8-16份、丹皮8-16份、女贞子13-18份、天麻15-18份、益智仁9-16份、远志6-10份、穿山甲8-15份、酒制何首乌15-20份、酒山茱萸肉15-20份、丹参10-15份、葛根10-15份、冬虫夏草3-8份、西红花5-12份;
(2)远志、葛根、穿山甲经酒制,然后与其他中药混合,加水,加热熬制,浓缩成膏状,制得本发明提供的用于治疗高血压疾病的中药组合物。
本发明提供的用于治疗高血压疾病的中药组合物的服用方法:每日早晚各服用一次,一次20-30毫升,90天为一个疗程。
本申请的申请人出生于医学世家,经过近三十年的学习研究,在中医学方面有很深的造诣。申请人结合阴阳五行对人体的作用,经数十年的艰苦研究,终于研制出了本发明用于治疗高血压疾病的中药组合物。采用本发明的中药组合物对300名高血压疾病患者进行了临床医学治疗,经一个疗程的药物治疗后,287名患者血压恢复正常,头痛、头晕等症状完全消失,其余13名患者血压明显下降,头痛、头晕等症状也明显缓解。经一个疗程治疗后,治愈率达到95.6%,有效率100%。剩余13名患者继续用本发明的中药组合物治疗,经一个疗程后,11名患者血压恢复正常,头痛、头晕等症状完全消失,其余两名患者又继续用本发明中药组合物治疗一个疗程,血压恢复正常,头痛、头晕等症状完全消失,亦完全治愈。患者治愈后进行了三年随访,所有患者经检测血压均正常,完全康复,无复发。本发明提供的用于治疗高血压疾病的中药组合物打破了西药只能控制血压而不能彻底治愈,血压反复,药不离口等医学难题。
在本发明提供的用于治疗高血压疾病的中药组合物中,各味原料药的功效和药理作用简单介绍如下。
三七:扩张血管、降低血压,改善微循环,增加血流量,预防和治疗心脑组织缺血、缺氧症;促进蛋白质、核糖核酸(RNA)、脱氧核糖核酸(DNA)合成,强身健体;促进血液细胞新陈代谢,平衡调节血液细胞;双向调节中枢神经,提高脑力,增强学习和记忆能力;增强机体免疫功能,抗肿瘤;止血、活血化瘀;保肝、抗炎;延缓衰老;双向调节血糖、降低血脂、胆固醇、抑制动脉硬化。
茯苓:茯苓性味甘淡平,入心、肺、脾经,具有渗湿利水,健脾和胃,宁心安神的功效。可治小便不利,水肿胀满,痰饮咳逆,呕逆,恶阻,泄泻,遗精,淋浊,惊悸,健忘等症。茯苓之利水,是通过健运脾肺功能而达到的,与其它直接利水的中药不同。
枸杞子:滋补肝肾,益精明目。用于虚劳精亏,腰膝酸痛,眩晕耳鸣,内热消渴,血虚萎黄,目昏不明。
黄芪:有益气固表、敛汗固脱、托疮生肌、利水消肿之功效。用于治疗气虚乏力,中气下陷,久泻脱肛,便血崩漏,表虚自汗,痈疽难溃,久溃不敛,血虚萎黄,内热消渴,慢性肾炎,蛋白尿,糖尿病等。
泽泻:利水渗湿;泄热通淋。主小便不利;热淋涩痛;水肿胀满;泄泻;痰饮眩晕;遗精。
石斛:滋阴清热、润肺养胃、强筋健骨,主治热病伤津、口干烦渴、胃痛干呕、咳嗽少痰等症。益胃生津,滋阴清热。胃生津,滋阴清热。用于阴伤津亏,口干烦渴,食少干呕,病后虚热,目暗不明。
白术:健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。土白术健脾,和胃,安胎。用于脾虚食少,泄泻便溏,胎动不安。
生地:味甘苦、性寒而入血分,清热凉血。主治阴虚发热,消渴,吐血,衄血,血崩,月经不调,胎动不安,阴伤便秘。功能为凉血清热、滋阴补肾、生津止渴,常用于治疗骨蒸痨热、咽喉燥痛、痰中带血等症。
熟地:味甘微温质润,既补血滋阴,又能补精益髓,具有补血滋阴功效,可用于血虚萎黄,眩晕,心悸失眠,月经不调,崩漏等症,亦可用于肾阴不足的潮热骨蒸、盗汗、遗精、消渴等症。
山药:主治脾胃虚弱、倦怠无力、食欲不振、久泄久痢、肺气虚燥、痰喘咳嗽、肾气亏耗、腰膝酸软、下肢痿弱、消渴尿频、遗精早泄、带下白浊、皮肤赤肿、肥胖等病症。具有健脾补肺、益胃补肾、固肾益精、聪耳明目、助五脏、强筋骨、长志安神、延年益寿的功效。
柏子仁:养心安神,润肠通便。用于虚烦不眠,心悸怔忡,肠燥便秘等症。对损伤造成的记忆再现障碍及记忆消去促进有明显的改善;对损伤致的获得障碍亦有改善倾向;对损伤造成的运动低下无拮抗作用。
酸枣仁:养肝,宁心,安神,敛汗。治虚烦不眠,惊悸怔忡,烦渴,虚汗。对中枢神经系统有显著的镇静及嗜睡现象;抗心律失常,能明显减轻缺氧、缺糖、氯丙嗪和丝裂霉素引起的大鼠乳鼠心肌细胞释放乳酸脱氢酸,表明其对心肌细胞损伤有保护作用;抗高血压及降血脂通过降低血脂和调理血脂蛋白,可能对动脉硬化形成和发展有抑制作用;抗烫伤能提高存活率,并延长存活时间。
丹皮:又称牡丹皮,清热凉血、活血散瘀。温热病热入血分;发斑;吐衄;热病后期热伏阴分发热;阴虚骨蒸潮热;血滞经闭;痛经;痈肿疮毒;跌扑伤痛;风湿热痹。
女贞子:补肝肾阴,乌须明目,现代医学研究认为女贞子可以抑制幽门螺杆菌的作用可以治疗胃病,还具有抑制嘌呤异常代谢用于痛风和高尿酸血症的治疗。
天麻:健脾燥湿,化痰熄风,补血,治头痛。
益智仁:温脾止泻,摄唾涎,暖肾,固精缩尿。用于脾寒泄泻,腹中冷痛,口多唾涎,肾虚遗尿,小便频数,遗精白浊。
远志:安神益智,祛痰,消肿。用于心肾不交引起的失眠多梦,健忘惊悸,神志恍惚,咳痰不爽,疮疡肿毒,乳房肿痛。
穿山甲:用于血滞经闭,症瘕结块,风湿痹痛、筋脉拘挛等症。穿山甲善于走窜,性专行散,能活血散瘀、通行经络、乳汁不通、痈肿初起或脓成不溃等症。
酒制何首乌:用于精血亏虚、头晕眼花、须发早白、腰膝酸软、遗精崩带等证。能补肝肾,益精血,兼能收敛,且不寒、不燥、不腻,故为滋补良药。可促进造血功能、增强免疫功能、降血脂与抗动脉粥样硬化及保肝。
酒山茱萸肉:补益肝肾,涩精固脱。用于眩晕耳鸣,腰膝酸痛,阳痿遗精,遗尿尿频,崩漏带下,大汗虚脱,内热消渴。主治肝肾不足,头晕目眩,耳鸣,腰酸。
丹参:可强心,加强心肌收缩力、改善心脏功能,不增加心肌耗氧量;可扩张冠脉,增加心肌血流量;扩张外周血管,血流增加,使脑血流量下降;抗血栓形成,提高纤溶酶活性;延长出、凝血时间;抑制血小板聚集;改善血液流变学特性;改善微循环。可活血祛瘀,调经止痛,除烦安神,凉血消痈。
葛根:调节内分泌、修护肌肤,对降低中老年人的血糖、血脂、血压升高有很好的疗效。
冬虫夏草:补肺固表,补肾益精。主治肺虚咳喘,劳嗽痰血,自汗盗汗,肾亏阳痿、遗精,腰膝酸痛。具有降血压作用。
西红花:活血化瘀,散郁开结。治忧思郁结,胸膈痞闷,吐血,伤寒发狂,惊怖恍惚,妇女经闭,产后瘀血腹痛,跌扑肿痛。
以上诸药合用,具有活血化瘀,推陈致新,养心生血,软坚散结,滋阴补肾,疏肝理气,祛痰定惊,通经络,舒筋骨,健脾胃等功效,适用于血不供心,心肾不交之症,对心血虚亏引起的高血压、心肌炎,动脉硬化,胸闷,压气,心悸,乏力,头晕,耳鸣,恶心,呕吐,不寐,肝肾阴阳失调等病症均具有治疗效果,尤其对高血压疾病具有显著的疗效。
在本发明提供的用于治疗高血压疾病的中药组合物中,通过各味中药的合理配伍,达到了标本兼治的治疗效果。不同于其他治疗方法只是起到了抗氧化保护人体内皮细胞,提高血管韧性弹性的作用,本发明提供的用于治疗高血压疾病的中药组合物可保护细胞内壁,促使干细胞再生,对体内坏死细胞具有推陈致新再生功能。
本发明的中药组合物为浓缩型膏剂,通过微量口服,达到治愈病症的功效。经临床验证,本发明的中药组合物疗效安全可靠,无毒副作用,饮用方便,易于吸收,疗效快,治愈率高。
具体实施方式
实施例1
本实施例提供的用于治疗高血压疾病的中药组合物,由以下重量的原料药制成:三七15克、茯苓20克、枸杞子20克、黄芪20克、泽泻10克、石斛10克、白术15克、生地10克、熟地15克、山药8克、柏子仁16克、酸枣仁8克、丹皮8克、女贞子18克、天麻15克、益智仁16克、远志6克、穿山甲8克、酒制何首乌20克、酒山茱萸肉15克、丹参10克、天然葛根10克、冬虫夏草8克、西红花12克。
本实施例提供的用于治疗高血压疾病的中药组合物的制备方法,包括以下步骤:
(1)按以下重量称取原料:三七15克、茯苓20克、枸杞子20克、黄芪20克、泽泻10克、石斛10克、白术15克、生地10克、熟地15克、山药8克、柏子仁16克、酸枣仁8克、丹皮8克、女贞子18克、天麻15克、益智仁16克、远志6克、穿山甲8克、酒制何首乌20克、酒山茱萸肉15克、丹参10克、天然葛根10克、冬虫夏草8克、西红花12克;
(2)远志、葛根、穿山甲经酒制,然后与其他中药混合,加水,加热熬制,浓缩成膏状,制得本发明提供的用于治疗高血压疾病的中药组合物。
实施例2
本实施例提供的用于治疗高血压疾病的中药组合物,由以下重量的原料药制成:三七20克、茯苓15克、枸杞子15克、黄芪15克、泽泻15克、石斛15克、白术10克、生地15克、熟地10克、山药16克、柏子仁8克、酸枣仁16克、丹皮16克、女贞子13克、天麻18克、益智仁9克、远志10克、穿山甲15克、酒制何首乌15克、酒山茱萸肉20克、丹参15克、天然葛根15克、冬虫夏草3克、西红花5克。
本实施例提供的用于治疗高血压疾病的中药组合物的制备方法同实施例1。
典型病例
病例1乔某,男,79岁,2008年4月12日就诊。于1997年确诊为高血压,至就诊时已患高血压十余年,就诊时高压达到180以上,低压120以上,并发冠状动脉硬化、脑血管淤塞、中风等症状,之前一直服用西药进行治疗。就诊后,停止服用其他治疗高血压的药物,采用本发明实施例1提供的中药组合物膏剂进行治疗,一个疗程后复诊,高压降到130,低压降到85,恢复正常,治疗后随访三年,没有服用任何药物,血压正常。
病例2王某,男,62岁,患高血压12年,确诊年龄50岁,于2009年2月11日就诊。当时高压到达175,低压到达105,并发脑梗、心慌。就诊后,停止服用其他治疗高血压的药物,采用本发明实施例2提供的中药组合物膏剂进行治疗,一个疗程后复诊,高压降到125,低压降到70。从2009年治愈至今无服用任何治疗高血压药物,血压正常,并发症减轻。
病例3朱某,男,45岁,2009年8月6日就诊。2008年确诊为高血压,高压165,低压112。就诊后,停止服用其他治疗高血压的药物,采用本发明实施例2提供的中药组合物膏剂进行治疗,一个疗程后复诊,高压降到125,低压降到80,从2009年治愈至今血压正常,未复发。
Claims (2)
1.一种用于治疗高血压疾病的中药组合物,其特征在于,由以下重量份数的原料药制成:
三七15-20份 茯苓15-20份 枸杞子15-20份 黄芪15-20份
泽泻10-15份 石斛10-15份 白术10-15份 生地10-15份
熟地10-15份 山药8-16份 柏子仁8-16份 酸枣仁8-16份
丹皮8-16份 女贞子13-18份 天麻15-18份 益智仁9-16份
远志6-10份 穿山甲8-15份 酒制何首乌15-20份
酒山茱萸肉15-20份丹参10-15份葛根10-15份冬虫夏草3-8份
西红花5-12份。
2.根据权利要求1所述的用于治疗高血压疾病的中药组合物,其特征在于,所述中药组合物为浓缩膏剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210046109.XA CN102526581B (zh) | 2012-02-27 | 2012-02-27 | 一种用于治疗高血压疾病的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210046109.XA CN102526581B (zh) | 2012-02-27 | 2012-02-27 | 一种用于治疗高血压疾病的中药组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102526581A CN102526581A (zh) | 2012-07-04 |
| CN102526581B true CN102526581B (zh) | 2014-05-21 |
Family
ID=46335401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210046109.XA Expired - Fee Related CN102526581B (zh) | 2012-02-27 | 2012-02-27 | 一种用于治疗高血压疾病的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102526581B (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105169214A (zh) * | 2015-07-15 | 2015-12-23 | 济南大学 | 一种治疗动脉粥样硬化的中药组合物及其制备方法 |
| CN107261105A (zh) * | 2017-06-26 | 2017-10-20 | 郑相国 | 治疗心脑血管疾病的中成药 |
| CN107970376A (zh) * | 2017-10-28 | 2018-05-01 | 王高 | 一种治疗心脑血管疾病的中药组合物 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1238976A (zh) * | 1998-06-12 | 1999-12-22 | 许世平 | 归精片 |
| CN101125169A (zh) * | 2006-08-18 | 2008-02-20 | 孙景荣 | 保健酒 |
| CN102068625A (zh) * | 2010-12-30 | 2011-05-25 | 蚌埠丰原涂山制药有限公司 | 一种降糖降压的中药组合物及其制备方法 |
-
2012
- 2012-02-27 CN CN201210046109.XA patent/CN102526581B/zh not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1238976A (zh) * | 1998-06-12 | 1999-12-22 | 许世平 | 归精片 |
| CN101125169A (zh) * | 2006-08-18 | 2008-02-20 | 孙景荣 | 保健酒 |
| CN102068625A (zh) * | 2010-12-30 | 2011-05-25 | 蚌埠丰原涂山制药有限公司 | 一种降糖降压的中药组合物及其制备方法 |
Non-Patent Citations (6)
| Title |
|---|
| 冬虫夏草的化学成分及药理学研究概况;李凤荣;《内蒙古中医药》;20100915(第17期);102页-105页 * |
| 左归饮加减治疗冠心病38例;翁景芹等;《中华医药杂志》;20050831;第5卷(第8期);846页-847页 * |
| 李伟平等.西红花的研究进展.《北京联合大学学报》.2011,第25卷(第3期),55页-58页. |
| 李凤荣.冬虫夏草的化学成分及药理学研究概况.《内蒙古中医药》.2010,(第17期),102页-105页. |
| 翁景芹等.左归饮加减治疗冠心病38例.《中华医药杂志》.2005,第5卷(第8期),846页-847页. |
| 西红花的研究进展;李伟平等;《北京联合大学学报》;20110930;第25卷(第3期);55页-58页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102526581A (zh) | 2012-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103432393B (zh) | 一种治疗高血压的中药组合物 | |
| CN101904994B (zh) | 治疗糖尿病的中药制剂 | |
| CN105362650A (zh) | 一种用于治疗便秘的药物组合物及其应用方法 | |
| CN104740437A (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
| CN104857288B (zh) | 治疗白发的中药制剂及其制备方法 | |
| CN102526581B (zh) | 一种用于治疗高血压疾病的中药组合物 | |
| CN106266999A (zh) | 一种治疗心神不安及心悸失眠的中药组合物及其制备方法 | |
| CN104383268A (zh) | 一种治疗高血压的中药组合物 | |
| CN102579799A (zh) | 一种治疗产后血虚发热型的中药组合物 | |
| CN101904984A (zh) | 治疗脱肛病的中草药 | |
| CN101095760A (zh) | 治疗糖尿病神经源性膀胱的中药组合 | |
| CN106362120A (zh) | 一种治疗高血糖和糖尿病的中药方剂 | |
| CN104208416A (zh) | 一种治疗心肌梗死的中药 | |
| CN105250569A (zh) | 一种用于治疗末梢神经炎的中药丸剂及制备方法 | |
| CN105362914A (zh) | 一种治疗慢性胃炎的中药组合物 | |
| CN105362827A (zh) | 一种可有效治疗贫血的汤剂药物及其制备方法 | |
| CN104117020A (zh) | 一种治疗心房颤动的中药配方 | |
| CN103463463A (zh) | 一种补血活血、祛风除湿的中药制剂 | |
| CN102552629B (zh) | 一种治疗风寒湿痹症的中药 | |
| CN101904965A (zh) | 治疗妇女妊娠腹痛的中草药 | |
| CN101112512A (zh) | 一种治疗先兆流产的中药制剂 | |
| CN101085141A (zh) | 一种治疗经行眩晕的中药 | |
| CN106362097A (zh) | 一种治疗肾阳虚的中药组合物及制备方法 | |
| CN106166233A (zh) | 一种治疗内分泌失调的中药组合物 | |
| CN106139111A (zh) | 一种可有效治疗抑郁症的中药组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140521 Termination date: 20180227 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |